EDITORIALS

Intravesical Therapy for Superficial Cancer: Need for More Options

E. David Crawford

JCO Aug 1 2002: 3185–3186. [Full Text] [PDF]

Challenge of Locally Persistent Prostate Cancer: An Unresolved Clinical Dilemma

Christopher J. Logothetis

JCO Aug 1 2002: 3187. [Full Text] [PDF]

Predicting Prostate-Specific Antigen Recurrence Established: Now, Who Will Survive?

Anthony V. D’Amico

JCO Aug 1 2002: 3188–3190. [Full Text] [PDF]

Bisphosphonates and Tumor Burden

Gregory R. Mundy

JCO Aug 1 2002: 3191–3192. [Full Text] [PDF]

ORIGINAL REPORTS
Genitourinary Cancer
	Phase I Trial of Intravesical Gemcitabine in Bacillus Calmette-Guérin–Refractory Transitional-Cell Carcinoma of the Bladder
	Guido Dalbagni, Paul Russo, Joel Sheinfeld, Madhu Mazumdar, William Tong, Farhang Rabbani, Machelle S. Donat, Harry W. Herr, Pramod Sogani, Dominique dePalma, and Dean Bajorin
	JCO Aug 1 2002: 3193–3198. [Abstract] [Full Text] [PDF]
	Radical Radiation for Localized Prostate Cancer: Local Persistence of Disease Results in a Late Wave of Metastases
	John J. Coen, Anthony L. Zietman, Harjot Thakral, and William U. Shipley
	JCO Aug 1 2002: 3199–3205. [Abstract] [Full Text] [PDF]
	International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy
	Markus Graefen, Pierre I. Karakiewicz, Ilias Cagiannos, David I. Quinn, Susan M. Henshall, John J. Grygiel, Robert L. Sutherland, Phillip D. Stricker, Eric Klein, Patrick Kupelian, Donald G. Skinner, Gary Lieskovsky, Bernard Bochner, Hartwig Huland, Peter G. Hammerer, Alexander Haese, Andreas Erbersdobler, James A. Eastham, Jean de Kernion, Thomas Cangiano, Fritz H. Schröder, Mark F. Wildhagen, Theo H. van der Kwast, Peter T. Scardino, and Michael W. Kattan
	JCO Aug 1 2002: 3206–3212. [Abstract] [Full Text] [PDF]
	Preoperative Combined Nested Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen and Prostate-Specific Membrane Antigen Does Not Correlate With Pathologic Stage or Biochemical Failure in Patients With Localized Prostate Cancer Undergoing Radical Prostatectomy
	John Thomas, Manjula Gupta, Ying Grasso, Chandana A. Reddy, Warren D. Heston, Craig Zippe, Robert Dreicer, Patrick A. Kupelian, Jennifer Brainard, Howard S. Levin, and Eric A. Klein
	JCO Aug 1 2002: 3213–3218. [Abstract] [Full Text] [PDF]

Breast Cancer
	Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
	Trevor Powles, Sandy Paterson, John A. Kanis, Eugene McCloskey, Sue Ashley, Alwynne Tidy, Kirsi Rosenqvist, Ian Smith, Lars Ottestad, Sandra Legault, Marjo Pajunen, Auli Nevantaus, Esa Männistö, Anne Suovuori, Sari Atula, Jaakko Nevalainen, and Liisa Pylkkänen
	JCO Aug 1 2002: 3219–3224. [Abstract] [Full Text] [PDF]

Sarcomas
	Clinical Features and Outcome of Initially Unresected Nonmetastatic Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma
	Sheri L. Spunt, D. Ashley Hill, Alison M. Motosue, Catherine A. Billups, Alvida M. Cain, Bhaskar N. Rao, Charles B. Pratt, Thomas E. Merchant, and Alberto S. Pappo
	JCO Aug 1 2002: 3225–3235. [Abstract] [Full Text] [PDF]
	Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressive AIDS-Related Kaposi’s Sarcoma: An AIDS Clinical Trials Group Clinical Study
	Scott R. Evans, Susan E. Krown, Marcia A. Testa, Timothy P. Cooley, and Jamie H. Von Roenn
	JCO Aug 1 2002: 3236–3241. [Abstract] [Full Text] [PDF]

Melanoma
	Enhanced Humoral Immune Response Correlates With Improved Disease-Free and Overall Survival in American Joint Committee on Cancer Stage II Melanoma Patients Receiving Adjuvant Polyvalent Vaccine
	L. Andrew DiFronzo, Rishab K. Gupta, Richard Essner, Leland J. Foshag, Steven J. O’Day, Leslie A. Wanek, Stacey L. Stern, and Donald L. Morton
	JCO Aug 1 2002: 3242–3248. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Phase I Study of Temozolomide in Relapsed/Refractory Acute Leukemia
	Karen Seiter, Delong Liu, Thomas Loughran, Ahmad Siddiqui, Paul Baskind, and Tauseef Ahmed
	JCO Aug 1 2002: 3249–3253. [Abstract] [Full Text] [PDF]
	Prognostic Significance of Partial Tandem Duplications of the MLL Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia Study Group Ulm
	Konstanze Döhner, Karen Tobis, Regina Ulrich, Stefan Fröhling, Axel Benner, Richard F. Schlenk, and Hartmut Döhner
	JCO Aug 1 2002: 3254–3261. [Abstract] [Full Text] [PDF]
	Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma
	Thomas E. Witzig, Ian W. Flinn, Leo I. Gordon, Christos Emmanouilides, Myron S. Czuczman, Mansoor N. Saleh, Larry Cripe, Gregory Wiseman, Teresa Olejnik, Pratik S. Multani, and Christine A. White
	JCO Aug 1 2002: 3262–3269. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297
	Jordan D. Berlin, Paul Catalano, James P. Thomas, John W. Kugler, Daniel G. Haller, and Al Bowen Benson, III
	JCO Aug 1 2002: 3270–3275. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Complication Rates Among Cancer Patients With Peripherally Inserted Central Catheters
	Louise J. Walshe, Sharp F. Malak, Janet Eagan, and Kent A. Sepkowitz
	JCO Aug 1 2002: 3276–3281. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Expression of Multidrug Resistance Genes MVP, MDR1, and MRP1 Determined Sequentially Before, During, and After Hyperthermic Isolated Limb Perfusion of Soft Tissue Sarcoma and Melanoma Patients
	Ulrike Stein, Karsten Jürchott, Matthias Schläfke, and Peter Hohenberger
	JCO Aug 1 2002: 3282–3292. [Abstract] [Full Text] [PDF]
	Clinical Pharmacokinetics of Irinotecan and Its Metabolites: A Population Analysis
	Rujia Xie, Ron H.J. Mathijssen, Alex Sparreboom, Jaap Verweij, and Mats O. Karlsson
	JCO Aug 1 2002: 3293–3301. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Nutrition and Survival After the Diagnosis of Breast Cancer: A Review of the Evidence
	Cheryl L. Rock and Wendy Demark-Wahnefried
	JCO Aug 1 2002: 3302–3316. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002
	Eric P. Winer, Clifford Hudis, Harold J. Burstein, Rowan T. Chlebowski, James N. Ingle, Stephen B. Edge, Eleftherios P. Mamounas, Julie Gralow, Lori J. Goldstein, Kathleen I. Pritchard, Susan Braun, Melody A. Cobleigh, Amy S. Langer, Judy Perotti, Trevor J. Powles, Timothy J. Whelan, and George P. Browman
	JCO Aug 1 2002: 3317–3327. First published on Jul 1 2002; 10.1200/JCO.2002.06.020. [Abstract] [Full Text] [PDF]
	American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition
	Rowan T. Chlebowski, Nananda Col, Eric P. Winer, Deborah E. Collyar, Steven R. Cummings, Victor G. Vogel, III, Harold J. Burstein, Andrea Eisen, Isaac Lipkus, and David G. Pfister
	JCO Aug 1 2002: 3328–3343. First published on Jul 1 2002; 10.1200/JCO.2002.06.029. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Challenging Cases and Diagnostic Dilemmas: Case 1. Tracheal Compression in Hodgkin's Disease

Mitchell A. Garrison, Christopher Glanton, Mark Rasnke, Michael E. Smith, and Deborah L. Ornstein

JCO Aug 1 2002: 3344–3347. [Full Text] [PDF]

Challenging Cases and Diagnostic Dilemmas: Case 2. Pitfalls of Positron Emission Tomography for Assessing Residual Mediastinal Mass After Chemotherapy for Hodgkin's Disease

J.B. Bomanji, R. Syed, C. Brock, P. Jankowska, A. Dogan, D.C. Costa, P.J. Ell, and S.M. Lee

JCO Aug 1 2002: 3347–3349. [Full Text] [PDF]

Challenging Cases and Diagnostic Dilemmas: Case 3. Positron Emission Tomography Scan Mimicking Lymph Node Metastases in a High-Risk Melanoma Patient

Konstanze Spieth, Jörg Risse, Roland Kaufmann, and Jens Gille

JCO Aug 1 2002: 3349–3351. [Full Text] [PDF]

ART OF ONCOLOGY

E-motions: Email for Written Emotional Expression

Florian Strasser, Michael Fisch, Diane C. Bodurka, Debra Sivesind, and Eduardo Bruera

JCO Aug 1 2002: 3352–3355. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Troxacitabine in Patients With Refractory Leukemia

Theodore Karrison, Mark Ratain, Sharyn D. Baker, Elizabeth Garrett, and Francis Giles

JCO Aug 1 2002: 3356–3357. [Full Text] [PDF]

HER-2/neu Serum Levels Vis-à-Vis Hormonal Response in Metastatic Breast Cancer

Lawrence C. Panasci, A. Lipton, S.M. Ali, K. Leitzel, L. Engle, and V. Chinchilli

JCO Aug 1 2002: 3357. [Full Text] [PDF]

Conformal Radiotherapy for High-Grade Gliomas: How Much Is Too Much?

Jonathan Knisely

JCO Aug 1 2002: 3357-a–3358. [Full Text] [PDF]

Radiotherapy Dose Escalation in High-Grade Gliomas

Michael A. LaCombe, June L. Chan, Howard M. Sandler, and Benedick A. Fraass

JCO Aug 1 2002: 3358–3359. [Full Text] [PDF]

Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid

C. Gedlicka, W. Scheithauer, B. Schüll, and G.V. Kornek

JCO Aug 1 2002: 3359–3361. [Full Text] [PDF]

ERRATA

ERRATA

JCO Aug 1 2002: 3361. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.